The acquisition includes Durect’s novel therapeutic molecule, larsucosterol, which has shown promising results in Phase 2 trials for treating alcoholic hepatitis (AH). Under the terms of the agreement ...

Investing.com -- Atossa Therapeutics Inc (NASDAQ: ATOS) stock surged 11.4% premarket following positive feedback from the U.S. Food and Drug Administration (FDA) regarding the company’s proposed dose ...

WASHINGTON (Reuters) -The U.S. trade deficit in goods narrowed to the lowest level in nearly two years in June as imports fell sharply, cementing economists’ expectations that trade likely accounted ...

Investing.com -- Scinai Immunotherapeutics Ltd. (NASDAQ: SCNI) stock surged 32.9% premarket following the publication of a peer-reviewed article validating the disease-modifying potential of its ...

The combined pre-tax profit for Nomura’s four business segments increased by ¥13.8 billion from the previous quarter. Fixed Income, Currencies and Commodities (FICC) revenue rose by ¥19 billion ...

D Systems (NYSE: DDD) stock rose 2.8% premarket following the announcement of the full commercial release of its NextDent Jetted Denture Solution for the U.S. market. The company’s first-to-market ...

Sysco Corporation (NYSE:SYY) reported better-than-expected fourth quarter results on Tuesday, with adjusted earnings per share exceeding analyst estimates, though shares fell 3.4% as investors focused ...

Investing.com -- Avis Budget Group Inc (NASDAQ: CAR) stock rose 3.9% premarket following the announcement of a multi-year strategic partnership with Waymo to launch a fully autonomous ride-hailing ...

Investing.com -- Marti Technologies Inc (NYSE: MRT) stock fell 6.7% after the Turkish mobility super app announced plans to hold approximately 20% of its cash reserves in Bitcoin as part of a new ...

Investing.com -- UBS said in a note Tuesday that investors should broaden their exposure to international equities as U.S.

Investing.com -- Nyxoah SA (BR:NYXH) (NASDAQ: NYXH) stock climbed 8.8% following the publication of its DREAM pivotal study data in the Journal of Clinical Sleep Medicine, which revealed strong ...

Investing.com -- Novo Nordisk (NYSE: NVO )’s guidance reduction and CEO resignation represent a "double surprise" according to BMO Capital Markets analyst Evan David Seigerman. In a note to clients, ...